Results 81 to 90 of about 4,664 (185)

A personalized DVH prediction model for HDR brachytherapy in cervical cancer treatment. [PDF]

Front Oncol, 2022
Li Z, Chen K, Yang Z, Zhu Q, Yang X, Li Z, Fu J.   +6 more
europepmc   +1 more source

Long term response stability of a well-type ionization chamber used in calibration of high dose rate brachytherapy sources

Journal of Medical Physics, 2010
Well-type ionization chamber is often used to measure strength of brachytherapy sources. This study aims to check long term response stability of High Dose Rate (HDR) -1000 Plus well-type ionization chamber in terms of reference air kerma rate (RAKR) of ...
Vandana S, Sharma S
doaj  

HDR-brachytherapy for accelerated partial breast irradiation: Long-term experience from a Japanese institution. [PDF]

J Contemp Brachytherapy, 2023
Yoshida K, Kotsuma T, Takaoka Y, Tamenaga S, Yamazaki H, Nose T, Murakami N, Inaba K, Akiyama H, Masui K, Takenaka T, Kubota H, Tselis N, Masuda N, Yasojima H, Takeda M, Mano M, Nakamura S, Utsunomiya K, Tanigawa N, Tanaka E.   +20 more
europepmc   +1 more source

Feasibility of MRI targeted single fraction HDR brachytherapy for localized prostate carcinoma: ProFocAL-study. [PDF]

J Cancer Res Clin Oncol, 2023
Hass P, Fischbach F, Pech M, Gawish A.
europepmc   +1 more source

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial. [PDF]

Radiat Oncol, 2022
Belliveau C, Barkati M, Delouya G, Taussky D, Beauchemin MC, Lambert C, Beaulieu L, Beliveau-Nadeau D, Nicolas B, Carrier JF, Vigneault E, Ménard C.   +11 more
europepmc   +1 more source

Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial. [PDF]

J Cancer Res Clin Oncol, 2023
Damm R, Wybranska J, Hass P, Walke M, Omari J, Pech M, Seidensticker R, Ricke J, Seidensticker M.   +8 more
europepmc   +1 more source

Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial. [PDF]

Clin Transl Radiat Oncol, 2022
Hannoun-Levi JM, Chand-Fouche ME, Pace-Loscos T, Gautier M, Gal J, Schiappa R, Pujol N.   +6 more
europepmc   +1 more source

Supportive Care for HDR Brachytherapy in Gynecological Cancer: A Single Center Experience. [PDF]

In Vivo
Meinecke D, Bruns F, Christiansen H, Steinkasserer L, Knöchelmann AC.   +4 more
europepmc   +1 more source

Implementation of a real-time, ultrasound-guided prostate HDR brachytherapy program. [PDF]

J Appl Clin Med Phys, 2021
Smith BR, Strand SA, Dunkerley D, Flynn RT, Besemer AE, Kos JD, Caster JM, Wagner BS, Kim Y.   +8 more
europepmc   +1 more source

HDR Brachytherapy in the Treatment of Skin Kaposi Sarcoma: A Mono-Institutional Series. [PDF]

Cancers (Basel)
Santo B, Ciurlia E, Barba MC, Cavalera E, Coppola R, De Franco P, De Matteis S, Di Paola G, Leone A, Papaleo A, Russo D, Rubini D, Rubini G, Sardaro A.   +13 more
europepmc   +1 more source